-

Professor Liansheng Zhang: A Common Condition with Major Consequences—Current Challenges and New Strategies in the Management of Iron Deficiency Anemia
Iron deficiency anemia (IDA) is the most common nutritional deficiency and the leading cause of anemia worldwide. Despite the availability of well-established diagnostic methods, IDA is often underestimated in clinical practice as a “minor condition.”
-

Professor Xiaohui Zhang: Building on 25 Years of Progress—Advancing High-Quality Development in Hematologic Immunology
In March, as spring brings renewed vitality to Beijing, the 9th Beijing Conference on Thrombosis and Hemostasis, together with the 7th Beijing Hematologic Oncology and Immunology Summit Forum, was held from March 27 to 28, 2026, coinciding with the 25th anniversary of the Hematology and Immunology Branch of the Chinese Society of Immunology.
-

Professor Hongmei Jing: From Nature Breakthroughs to Clinical Practice—Advances in Precision Diagnosis and Treatment of Lymphoma
In March, as spring brings renewed vitality to Beijing, the 9th Beijing Conference on Thrombosis and Hemostasis, together with the 7th Beijing Hematologic Oncology and Immunology Summit Forum, was held from March 27 to 28, 2026. Centered on advances in the diagnosis and treatment of thrombotic and hemostatic disorders, as well as hematologic malignancies and…
-

Professor Zonghong Shao:Immune Dysregulation in Myelodysplastic Syndromes and Clinical Management Strategies
In March, as spring brings renewed vitality to Beijing, the 9th Beijing Conference on Thrombosis and Hemostasis, together with the 7th Beijing Hematologic Oncology and Immunology Summit Forum, was held from March 27 to 28, 2026. Centered on advances in the diagnosis and treatment of thrombotic and hemostatic disorders, as well as hematologic malignancies and…
-

Professor Junmin Li: Exploration and Clinical Practice of Umbilical Cord Blood Therapy in Elderly Patients with Acute Myeloid Leukemia
In March, as spring brings clarity and renewal to Beijing, the 9th Beijing Conference on Thrombosis and Hemostasis, together with the 7th Beijing Hematologic Oncology and Immunology Summit Forum, was convened from March 27 to 28, 2026, marking the 25th anniversary of the Hematology and Immunology Branch of the Chinese Society of Immunology.
-

Professor Zhenyu Yan: Seven Transformations in the Comprehensive Management of Hemophilia in China — From Survival to Functional Cure
In March, as spring breathes new life into Beijing, the 9th Beijing Conference on Thrombosis and Hemostasis, organized by the Hematology and Immunology Branch of the Chinese Society of Immunology, together with the 7th Beijing Hematologic Oncology and Immunology Summit Forum, was successfully convened from March 27 to 28, 2026. During the meeting, Professor Zhenyu…
-

Professor Gang Zhu: Prevention and Treatment of Urologic Tumors — Early Screening Is Key, Personalized Care Enhances Patient Experience
With the aging population and changes in lifestyle in China, the incidence of urologic cancers has been steadily increasing. Oncology Frontier – UroStream invited Professor Gang Zhu from Beijing United Family Hospital to discuss prevention strategies and personalized medical care in urologic oncology. Drawing from clinical practice, he emphasized the importance of early screening and…
-

Bladder Preservation Strategies in MIBC | Yiping Zhu: New Approaches and Clinical Practice
Bladder-preserving treatment is an important therapeutic strategy for patients with muscle-invasive bladder cancer (MIBC), aiming to maintain bladder function while avoiding radical cystectomy. In recent years, this approach has become a major focus of clinical research, with multiple emerging strategies.